The genous TM endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 2, 2012, Pages 231-242

  Van Beusekom, Heleen M M ^a   Ertaş, Gökhan ^a   Sorop, Oana ^a   Serruys, Patrick W ^a   Van Der Giessen, Willem J ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

CD34; coronary stent coatings; endothelium; neointima; restenosis

Indexed keywords

ACETYLSALICYLIC ACID; CD34 ANTIBODY; CLOPIDOGREL; HEPARIN; IMMUNOGLOBULIN G; KI 67 ANTIGEN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTERY INTIMA PROLIFERATION; ARTICLE; BARE METAL STENT; CARDIOVASCULAR RESPONSE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; ENDOTHELIAL PROGENITOR CELL; FEMALE; HEART MUSCLE REVASCULARIZATION; MALE; NONHUMAN; SAFETY; SWINE; VASCULAR ENDOTHELIUM; ANIMAL; CELL PROLIFERATION; CORONARY BLOOD VESSEL; DISEASE MODEL; HYPERPLASIA; INTIMA; METHODOLOGY; NEOINTIMA; PATHOLOGY; PROSTHESIS; RESTENOSIS; STEM CELL; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; CELL PROLIFERATION; CORONARY RESTENOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; FEMALE; HYPERPLASIA; MALE; MYOCARDIAL REVASCULARIZATION; NEOINTIMA; PROSTHESIS DESIGN; STEM CELLS; STENTS; SWINE; TUNICA INTIMA;

EID: 84856258546     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22928     Document Type: Article

References (48)

1. van Beusekom HM, Saia F, Zindler JD, Lemos PA, Hoor SL, van Leeuwen MA, de Feijter PJ, Serruys PW, van der Giessen WJ,. Drug-eluting stents show delayed healing: Paclitaxel more pronounced than sirolimus. Eur Heart J 2007; 28: 974-979. (Pubitemid 47343915)
2. Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, Ligthart JM, van Essen D, de Feyter PJ, Serruys PW,. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006; 27: 166-170. (Pubitemid 43069032)
3. Togni M, Raber L, Cocchia R, Wenaweser P, Cook S, Windecker S, Meier B, Hess OM,. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 2007; 120: 212-220. (Pubitemid 47042255)
4. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R,. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202. (Pubitemid 43929240)
5. Aoki J, Serruys PW, van Beusekom H, et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 2005; 45: 1574-1579. (Pubitemid 40704488)
6. Rogers C, Parikh S, Seifert P, Edelman ER,. Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair. Circulation 1996; 94: 2909-2914. (Pubitemid 26411759)
7. Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, Kutryk M, Serruys P,. Role of the endothelium in modulating neointimal formation: Vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 2004; 44: 733-739. (Pubitemid 39099565)
8. Ong AT, Aoki J, Kutryk MJ, Serruys PW,. How to accelerate the endothelialization of stents. Arch Mal Coeur Vaiss 2005; 98: 123-126. (Pubitemid 350002432)
9. Bjorkerud S, Bondjers G,. Arterial repair and atherosclerosis after mechanical injury. Tissue response after induction of a large superficial transverse injury. Atherosclerosis 1973; 18: 235-255.
10. Haudenschild CC, Schwartz SM,. Endothelial regeneration. II. Restitution of endothelial continuity. Lab Invest 1979; 41: 407-418. (Pubitemid 10164032)
11. van der Giessen WJ, Serruys PW, Visser WJ, Verdouw PD, van Schalkwijk WP, Jongkind JF,. Endothelialization of intravascular stents. J Interv Cardiol 1988; 1: 109-120.
12. Dichek DA, Neville RF, Zwiebel JA, Freeman SM, Leon MB, Anderson WF,. Seeding of intravascular stents with genetically engineered endothelial cells. Circulation 1989; 80: 1347-1353. (Pubitemid 19282525)
13. Flugelman MY, Dichek DA,. Seeding of intracoronary stents with endothelial cells: Current status and future prospects. J Interv Cardiol 1995; 8: 383-385.
14. Kutryk MJ, van Dortmont LM, de Crom RP, van der Kamp AW, Verdouw PD, van der Giessen WJ,. Seeding of intravascular stents by the xenotransplantation of genetically modified endothelial cells. Semin Interv Cardiol 1998; 3: 217-220.
15. Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001; 7: 1035-1040. (Pubitemid 32937384)
16. Bordenave L, Fernandez P, Remy-Zolghadri M, Villars S, Daculsi R, Midy D,. In vitro endothelialized ePTFE prostheses: clinical update 20 years after the first realization. Clin Hemorheol Microcirc 2005; 33: 227-234. (Pubitemid 41433857)
17. Bhattacharya V, McSweeney PA, Shi Q, Bruno B, Ishida A, Nash R, Storb RF, Sauvage LR, Hammond WP, Wu MH,. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 2000; 95: 581-585. (Pubitemid 30041673)
18. Shirota T, Yasui H, Shimokawa H, Matsuda T,. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 2003; 24: 2295-2302. (Pubitemid 36434048)
19. Shirota T, He H, Yasui H, Matsuda T,. Human endothelial progenitor cell-seeded hybrid graft: Proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng 2003; 9: 127-136. (Pubitemid 36228184)
20. He H, Shirota T, Yasui H, Matsuda T,. Canine endothelial progenitor cell-lined hybrid vascular graft with nonthrombogenic potential. J Thorac Cardiovasc Surg 2003; 126: 455-464. (Pubitemid 37048512)
21. Kutryk MJB, Kuliszewski MA,. In vivo endothelial progenitor cell seeding for the accelerated endothelialization of endovascular devices. Am J Cardiol 2003; 92 (6 abstract suppl. 1):94L:TCT-215.
22. Ward MR, Stewart DJ, Kutryk MJ,. Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives. Catheter Cardiovasc Interv 2007; 70: 983-998.
23. van Beusekom HMM, Sorop O, Weymaere M, Duncker D, van der Giessen WJ,. The neointimal response to stents eluting Tacrolimus from a degradable coating depends on the balance between polymer degradation and drug release. Eurointervention 2008; 4: 139-147.
24. van Beusekom HM, Whelan DM, Hofma SH, Krabbendam SC, van Hinsbergh VW, Verdouw PD, van der Giessen WJ,. Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. J Am Coll Cardiol 1998; 32: 1109-1117. (Pubitemid 28459607)
25. van Beusekom HMM, Whelan DM, van der Plas M, van der Giessen WJ,. A practical and rapid method of histological processing for examination of coronary arteries containing metallic stents. Cardiovasc Pathol 1996; 5: 69-76. (Pubitemid 26106532)
26. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR,. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 19: 267-274.
27. Whelan DM, van der Giessen WJ, Krabbendam SC, van Vliet EA, Verdouw PD, Serruys PW, van Beusekom HM,. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000; 83: 338-345. (Pubitemid 30313341)
28. Nakazawa G, Granada JF, Alviar CL, et al. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc Interv 2010; 3: 68-75.
29. Duckers HJ, Soullié T, den Heijer P, et al. Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: Final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)â.,¢. EuroInterv 2007; 3: 350-358.
30. Duckers HJ, Onuma Y, Benit E, et al. Final results of the HEALING 2b Trial to evalyate a Bioengineered CD34 antibody coated stent (Genous Stent) Designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. Abstract American Heart Association 2008.
31. Chong E, Poh KK, Liang S, et al. Two-Year Clinical Registry Follow-up of Endothelial Progenitor Cell Capture Stent Versus Sirolimus-Eluting Bioabsorbable Polymer-Coated Stent Versus Bare Metal Stents in Patients Undergoing Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction. J Interv Cardiol 2008; 23: 101-108.
32. Silber S, De Winter RJ, Grisold M, Wojcik J, Suryapranata H, Ribeiro E, Hian S,. Clinical outcome for the endothelial progenitor cells capturing genous stent: first results of the 1-year follow-up in 5000 patients. Abstract American Heart Association 2008.
33. Doornekamp FN, Borst C, Haudenschild CC, Post MJ,. Fogarty and percutaneous transluminal coronary angioplasty balloon injury induce comparable damage to the arterial wall but lead to different healing responses. J Vasc Surg 1996; 24: 843-850. (Pubitemid 26378610)
34. Hofma SH, Whelan DM, van Beusekom HM, Verdouw PD, van der Giessen WJ,. Increasing arterial wall injury after long-term implantation of two types of stent in a porcine coronary model. Eur Heart J 1998; 19: 601-609. (Pubitemid 28224682)
35. Arts CH, Hedeman Joosten PP, Blankensteijn JD, Staal FJ, Ng PY, Heijnen-Snyder GJ, Sixma JJ, Verhagen HJ, de Groot PG, Eikelboom BC,. Contaminants from the transplant contribute to intimal hyperplasia associated with microvascular endothelial cell seeding. Eur J Vasc Endovasc Surg 2002; 23: 29-38. (Pubitemid 41079204)
36. Schober A, Hoffmann R, Opree N, Knarren S, Iofina E, Hutschenreuter G, Hanrath P, Weber C,. Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease. Am J Cardiol 2005; 96: 1116-1122. (Pubitemid 41416606)
37. Kaul U, Bhatia V, Ghose T, Gupta R, Kachru R, Singh G,. Angiographic follow-up of genous bioengineered stent in acute myocardial infarction (GENAMI)-a pilot study. Indian Heart J 2008; 60: 532-535.
38. Rossi ML, Zavalloni D, Gasparini GL, Mango R, Belli G, Presbitero P,. The first report of late stent thrombosis leading to acute myocardial infarction in patient receiving the new endothelial progenitor cell capture stent. Int J Cardiol 2010; 141: e20-e22.
39. Rotmans JI, Heyligers JM, Verhagen HJ, Velema E, Nagtegaal MM, de Kleijn DP, de Groot FG, Stroes ES, Pasterkamp G,. In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 2005; 112: 12-18. (Pubitemid 40962563)
40. Cervinca P,. A randomized comparison of Genous stent vs chromium-cobalt stent for treatment of ST-Elevation myocardial infarction. A 6-month clinical, angiographic and IVUS follow-up. GENIUS-STEMI trial. Abstract, American College of Cardiology 2009 Scientific Sessions; Late-breaking clinical trials 1 2009.
41. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM,. Smooth muscle progenitor cells in human blood. Circulation 2002; 106: 1199-1204. (Pubitemid 34988636)
42. Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T, Shimizu M, Komoda H, Node K,. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: Impact on restenosis. Circulation 2007; 115: 553-561. (Pubitemid 46226164)
43. May AE, Seizer P, Gawaz M,. Platelets: Inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 2008; 28: s5-10.
44. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S,. Endothelial progenitor cells: New hope for a broken heart. Circulation 2003; 107: 3093-3100. (Pubitemid 36758985)
45. Blindt R, Vogt F, Astafieva I, Fach C, Hristov M, Krott N, Seitz B, Kapurniotu A, Kwok C, Dewor M, and others. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol 2006; 47: 1786-1795.
46. Walker LN, Bowyer DE,. Endothelial healing in the rabbit aorta and the effect of risk factors for atherosclerosis. Hypercholesterolemia. Arteriosclerosis 1984; 4: 479-488. (Pubitemid 14004794)
47. Dimmeler S, Zeiher AM,. Vascular repair by circulating endothelial progenitor cells: The missing link in atherosclerosis? J Mol Med 2004; 82: 671-677. (Pubitemid 39468491)
48. Jung C, Rafnsson A, Shemyakin A, Bohm F, Pernow J,. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes. Int J Cardiol 2010; 143: 368-372.